Found 6 matching trials
Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load PHASE2 The goal of this research study is to determine whether changes in organ-sp...
Show More Location
University of Tennessee Graduate School of Medicine
Learn More & Join Trial
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR PHASE2 This was a single center, prospective cohort study that is evaluating the a...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial
A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis PHASE2 This study is designed to assess the repeatability of organ-specific quanti...
Show More Location
PET/CT Imaging of Berkeley
Learn More & Join Trial
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis PHASE2 This is a single center prospective study evaluating 124I-evuzumitide in pa...
Show More Location
Oregon Health & Science University
Learn More & Join Trial
Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load PHASE1 Background:
Anakinra is a drug used to treat people with certain diseases ...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome PHASE2 This clinical trial will use the amyloid-binding radiotracer, 124I-evuzamit...
Show More Status
Enrolling By Invitation
Location
University of Tennessee Graduate School of Medicine
Learn More & Join Trial